Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics.

European Paediatric Regulation excipients flexible dose medicines for children mini-tablets pediatric formulations solid dosage forms

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
17 Jan 2022
Historique:
received: 20 12 2021
revised: 08 01 2022
accepted: 14 01 2022
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 22 1 2022
Statut: epublish

Résumé

In the treatment of pediatric diseases, mass-produced dosage forms are often not suitable for children. Commercially available medicines are commonly manipulated and mixed with food by caregivers at home, or extemporaneous medications are routinely compounded in the hospital pharmacies to treat hospitalized children. Despite considerable efforts by regulatory agencies, the pediatric population is still exposed to questionable and potentially harmful practices. When designing medicines for children, the ability to fine-tune the dosage while ensuring the safety of the ingredients is of paramount importance. For these purposes solid formulations may represent a valid alternative to liquid formulations for their simpler formula and more stability, and, to overcome the problem of swelling ability, mini-tablets could be a practicable option. This review deals with the different approaches that may be applied to develop mini-tablets intended for pediatrics with a focus on the safety of excipients. Alongside the conventional method of compression, 3D printing appeared particularly appealing, as it allows to reduce the number of ingredients and to avoid both the mixing of powders and intermediate steps such as granulation. Therefore, this technique could be well adaptable to the daily galenic preparations of a hospital pharmacy, thus leading to a reduction of the common practice of off-label preparations.

Identifiants

pubmed: 35056165
pii: ph15010108
doi: 10.3390/ph15010108
pmc: PMC8779937
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Am Dent Assoc. 2014 Feb;145(2):141-9
pubmed: 24487605
J Autism Dev Disord. 2019 Aug;49(8):3218-3230
pubmed: 31079275
Pharmaceutics. 2020 Apr 01;12(4):
pubmed: 32244848
Pharmacol Res. 2011 Sep;64(3):169-75
pubmed: 21376810
Pharm Res. 2018 Jan 16;35(2):34
pubmed: 29368113
Int J Pharm. 2019 Feb 10;556:106-116
pubmed: 30513398
J Immunother Cancer. 2018 Apr 30;6(1):30
pubmed: 29712574
Dan Med J. 2017 Feb;64(2):
pubmed: 28157063
Int J Pharm. 2020 Nov 30;590:119953
pubmed: 33039491
Expert Opin Drug Saf. 2011 Jul;10(4):499-502
pubmed: 21417862
Ther Drug Monit. 2014 Jun;36(3):278-87
pubmed: 24305628
JAMA. 1985 Nov 1;254(17):2422-30
pubmed: 3930760
Int J Pharm. 2018 Apr 25;541(1-2):136-142
pubmed: 29474896
J Pharm Sci. 2021 Sep;110(9):3276-3288
pubmed: 34097976
J Pediatr. 2018 Oct;201:202-207.e1
pubmed: 29960767
Arch Dis Child. 2015 Jul;100(7):694-9
pubmed: 25854872
Curr Drug Deliv. 2020;17(6):505-510
pubmed: 32384031
Arch Dis Child. 2016 Jul;101(7):662-9
pubmed: 26979250
Pharmaceut Med. 2018;32(4):251-258
pubmed: 30174435
Drug Dev Ind Pharm. 2017 Nov;43(11):1770-1779
pubmed: 28581832
Int J Pharm. 2019 Dec 15;572:118804
pubmed: 31678381
Contemp Clin Trials Commun. 2019 Jun 08;15:100393
pubmed: 31249901
Eur J Pharm Biopharm. 2017 May;114:213-220
pubmed: 28167295
Adv Drug Deliv Rev. 2014 Jun;73:89-101
pubmed: 24239480
Acta Pharm. 2015 Dec;65(4):365-82
pubmed: 26677895
Pharmaceutics. 2021 Mar 09;13(3):
pubmed: 33803163
JPEN J Parenter Enteral Nutr. 1987 Mar-Apr;11(2):169-71
pubmed: 3108538
Eur J Pharm Biopharm. 2020 Dec;157:59-65
pubmed: 33022389
Pharmaceuticals (Basel). 2021 Feb 11;14(2):
pubmed: 33670158
Eur J Pharm Biopharm. 2011 Aug;78(3):462-9
pubmed: 21324357
Int J Pharm. 2020 Sep 25;587:119571
pubmed: 32652180
AAPS PharmSciTech. 2021 Jan 8;22(1):40
pubmed: 33417081
BMJ Paediatr Open. 2018 Jan 29;2(1):e000198
pubmed: 29637186
J Pharm Sci. 2018 Apr;107(4):1204-1208
pubmed: 29233726
Curr Pharm Des. 2017;23(38):5779-5789
pubmed: 28950820
Pharmaceutics. 2019 Nov 26;11(12):
pubmed: 31779123
Int J Pharm. 2015 Mar 1;480(1-2):137-42
pubmed: 25596415
Ann Pharmacother. 2008 Jan;42(1):46-52
pubmed: 18056832
Eur J Pharm Biopharm. 2020 Nov;156:11-19
pubmed: 32871197
Int J Pharm. 2020 Jan 25;574:118905
pubmed: 31809860
J Pediatr. 2013 Dec;163(6):1728-1732.e1
pubmed: 23972645
Adv Ther. 2020 Jul;37(7):3299-3310
pubmed: 32451952
Pharmaceutics. 2021 May 15;13(5):
pubmed: 34063499
N Engl J Med. 2017 Jun 15;376(24):2341-2348
pubmed: 28468518
Int J Pharm. 2016 Mar 16;500(1-2):336-44
pubmed: 26804927
Med Etika Bioet. 2002 Spring-Summer;9(1-2):12-9
pubmed: 16276663
Arch Dis Child. 2013 Sep;98(9):725-31
pubmed: 23853004
Curr Drug Deliv. 2016;13(5):730-41
pubmed: 26456211
Expert Opin Drug Deliv. 2016;13(4):493-506
pubmed: 26559519
J Pediatr. 2015 Oct;167(4):893-896.e2
pubmed: 26259675
Int J Pharm. 2021 Mar 15;597:120296
pubmed: 33524524
Int J Pharm. 2021 Mar 15;597:120336
pubmed: 33545280
Expert Opin Drug Deliv. 2015;12(11):1727-40
pubmed: 26165848

Auteurs

Guendalina Zuccari (G)

Department of Pharmacy, University of Genoa, Viale Cembrano, 16148 Genoa, Italy.

Silvana Alfei (S)

Department of Pharmacy, University of Genoa, Viale Cembrano, 16148 Genoa, Italy.

Danilo Marimpietri (D)

Stem Cell Laboratory and Cell Therapy Center, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini 5, 16147 Genoa, Italy.

Valentina Iurilli (V)

Pharmacy, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini 5, 16147 Genoa, Italy.

Paola Barabino (P)

Pharmacy, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini 5, 16147 Genoa, Italy.

Leonardo Marchitto (L)

Department of Sciences for the Quality of Life, University of Bologna, Corso D'Augusto 237, 47921 Rimini, Italy.

Classifications MeSH